WuXi Biologics (Cayman) Inc
HKEX:2269
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
CN |
|
M
|
Medipharm Labs Corp
OTC:MEDIF
|
CA |
|
Ugro Capital Ltd
NSE:UGROCAP
|
IN |
|
P
|
Powszechny Zaklad Ubezpieczen SA
WSE:PZU
|
PL |
|
Q
|
Quidel Corp
XBER:QL1
|
US |
|
Q
|
Q2 Holdings Inc
F:0Q2
|
US |
|
A
|
Aramis Group SAS
F:6T6
|
FR |
|
Implenia AG
OTC:IPLNF
|
CH |
|
T
|
Technogym SpA
XBER:TN2
|
IT |
Wall St Price Targets
Price Targets Summary
WuXi Biologics (Cayman) Inc
According to Wall Street analysts, the average 1-year price target for WuXi Biologics (Cayman) Inc is 45.74 HKD with a low forecast of 30.3 HKD and a high forecast of 81.63 HKD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is WuXi Biologics (Cayman) Inc's stock price target?
Price Target
45.74
HKD
According to Wall Street analysts, the average 1-year price target for WuXi Biologics (Cayman) Inc is 45.74 HKD with a low forecast of 30.3 HKD and a high forecast of 81.63 HKD.
What is the Revenue forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
11%
Over the last 10 years, the compound annual growth rate for Revenue has been 44%. The projected CAGR for the next 8 years is 11%.
What is the Gross Profit forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
11%
Over the last 10 years, the compound annual growth rate for Gross Profit has been 49%. The projected CAGR for the next 8 years is 11%.
What is the Operating Income forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
15%
Over the last 10 years, the compound annual growth rate for Operating Income has been 60%. The projected CAGR for the next 8 years is 15%.
What is the Pre-Tax Income forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
18%
Over the last 10 years, the compound annual growth rate for Pre-Tax Income has been 60%. The projected CAGR for the next 3 years is 18%.
What is the Net Income forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
13%
Over the last 10 years, the compound annual growth rate for Net Income has been 60%. The projected CAGR for the next 8 years is 13%.
